[1]
Yang, H. et al. 2021. Effectiveness and safety evaluation of thrice weekly double strength vs daily single strength trimethoprim-sulfamethoxazole for prophylaxis of pneumocystis jirovecii pneumonia after kidney transplantation: a two year prospective cohort study. Journal of Pharmacy & Pharmaceutical Sciences. 24, (May 2021), 220–226. DOI:https://doi.org/10.18433/jpps31488.